Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
Abbott Reports 17.4 Percent Sales Growth
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Novartis makes strong start for the year
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
GSK welcomes key agreement to support global preparedness against pandemic influenza
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Roche Group's first-quarter 2011 sales on track for full-year targets
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Pfizer Announces Top-Line Results of Third Phase 3 Clinical Trial of Tofacitinib (CP-690,550)
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Bayer's Rivaroxaban Submitted for Approval in Japan
- Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease
- Forest Laboratories Completes Acquisition of Clinical Data, Inc.
- Nycomed acquires distribution rights to product portfolio in Turkey
- Novartis discontinues clinical trial of Tasigna®
- Boehringer Ingelheim maintains sales level/course set for the future: product pipeline well-filled
- Pfizer and Medivation Announce Results from Phase 3 HORIZON Trial of Dimebon in Huntington Disease